FSA Strategy for GLP-1 Medications: Pay Pre-Tax for Weight Loss Treatment
Your Flexible Spending Account can cover your entire year of GLP-1 medication costs with pre-tax dollars. Here is how to plan your FSA election for maximum benefit.
A Flexible Spending Account lets you pay for medical expenses with pre-tax dollars, effectively discounting your semaglutide or tirzepatide by your marginal tax rate. If you are in the 24% tax bracket, your $99/mo semaglutide effectively costs $75/mo through an FSA. The key is planning your election amount during open enrollment.
Disclaimer
This article provides general financial information. Consult your benefits administrator or a financial advisor for guidance specific to your plan.
FSA Basics for GLP-1 Users
An FSA is an employer-sponsored benefit that lets you set aside pre-tax dollars for qualified medical expenses. Unlike an HSA, you do not need a high-deductible health plan to use an FSA. Contributions reduce your taxable income and are also exempt from FICA taxes, saving you both income tax and Social Security/Medicare taxes.
FSA Savings Calculator
| Medication | Annual Cost | Tax Savings (24%) | FICA Savings | Effective Cost |
|---|---|---|---|---|
| Semaglutide ($99/mo) | $1,188 | $285 | $91 | $812 |
| Tirzepatide ($125/mo) | $1,500 | $360 | $115 | $1,025 |
Planning Your FSA Election
During open enrollment, calculate your expected GLP-1 medication costs for the year plus other anticipated medical expenses. For Trimi's semaglutide at $99/mo, that is $1,188 annually. Add in provider visits, lab work, dental, vision, and other medical costs. Elect the total amount up to the $3,200 maximum.
A key FSA advantage: your full elected amount is available on January 1, even though contributions are deducted from paychecks throughout the year. This means you can front-load medication purchases if needed.
Managing the Use-It-or-Lose-It Rule
Avoiding Forfeiture
- Plan accurately: Base your election on predictable expenses like monthly GLP-1 costs
- Check your plan: Does your employer offer a $640 carryover or 2.5-month grace period?
- Stock up: Purchase additional eligible supplies before year-end (sunscreen, first aid, etc.)
- Schedule appointments: Fit dental cleanings, vision exams, or wellness visits into the plan year
- Review mid-year: Some qualifying life events allow mid-year FSA election changes
What FSA Covers Beyond GLP-1
To make the most of your FSA, know the full range of eligible expenses. Beyond your GLP-1 medication, FSA covers prescription medications, copays and deductibles, dental care, vision care (glasses, contacts, exams), mental health services, chiropractic care, acupuncture, medical equipment, and many over-the-counter products including pain relievers, allergy medications, and sunscreen.
FSA vs. HSA: Which Is Better for GLP-1?
FSA Advantages
- No HDHP required
- Full amount available day one
- FICA tax savings (7.65%)
- Available with any health plan
HSA Advantages
- Funds roll over forever
- Can be invested for growth
- Portable between employers
- Higher contribution limits
Pro Tips for GLP-1 FSA Users
Pay for your Trimi subscription with your FSA debit card for automatic pre-tax billing. If your FSA does not issue a card, submit receipts for reimbursement promptly. Keep all pharmacy receipts and explanation of benefits statements. If you start GLP-1 medication mid-year, you may qualify for a qualifying life event that allows an FSA election change. And if your spouse also has FSA access, you can each elect up to $3,200 for a combined $6,400 in pre-tax medical funds.
The Bottom Line
An FSA is one of the simplest ways to reduce the cost of GLP-1 treatment. With predictable monthly costs from Trimi ($99/mo semaglutide or $125/mo tirzepatide), you can plan your FSA election with confidence and save 30% or more through tax benefits. If your employer offers an FSA, take advantage of it during your next open enrollment.
Predictable Pricing for Easy FSA Planning
Trimi: semaglutide $99/mo, tirzepatide $125/mo. FSA and HSA accepted.
View PricingMore on financial strategies
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program.
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).